Table 1 Patient characteristics
Information of HRM and LRM breast cancer patients | ||||
|---|---|---|---|---|
Characteristic | HRM patients | LRM patients | ||
No. | (%) | No. | (%) | |
Overall | 22 | 100.0 | 56 | 100.0 |
Age, years | ||||
 ⩽39 | 6 | 27.3 | 15 | 26.8 |
 40–49 | 2 | 9.1 | 12 | 21.4 |
 50–59 | 7 | 31.8 | 20 | 35.7 |
 ⩾60 | 7 | 31.8 | 9 | 16.1 |
Estrogen receptor status | ||||
 Positive | 10 | 45.5 | 24 | 42.9 |
 Negative | 12 | 54.5 | 32 | 57.1 |
Progesterone receptor status | ||||
 Positive | 9 | 40.9 | 20 | 35.7 |
 Negative | 13 | 59.1 | 36 | 64.3 |
HER2 status | ||||
 Positive | 3 | 13.6 | 7 | 12.5 |
 Negative/unknown | 19 | 86.4 | 49 | 87.5 |
Adjuvant hormonal treatment | ||||
 Yes | 8 | 36.4 | 28 | 50.0 |
 No/unknown | 14 | 63.6 | 28 | 50.0 |
Molecular subtype | ||||
 Luminal | 11 | 50.0 | 27 | 48.2 |
 TNBC | 7 | 31.8 | 18 | 32.1 |
 HER2 | 1 | 4.5 | 5 | 8.9 |
 Non-luminal | 3 | 13.6 | 6 | 10.7 |
